
  Mrv0541 02231217312D          

 11 10  0  0  0  0            999 V2000
    1.7605    1.0164    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750    1.4289    0.0000 V   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750    2.2539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1895    1.0164    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9039    1.4289    0.0000 V   0  0  0  0  0  0  0  0  0  0  0  0
    4.3164    0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4914    2.1434    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6184    1.8414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    1.4289    0.0000 V   0  0  0  0  0  0  0  0  0  0  0  0
    6.0474    1.8414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    0.6039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  5  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB04219

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
Trivanadate

> <CHEMICAL_FORMULA>
H6O8V3

> <MOLECULAR_WEIGHT>
286.8673

> <EXACT_MASS>
286.838158193

> <IUPAC_NAME>
trivanadoxane-1,1,3,3,5,5-hexol

> <IUPAC_TRADITIONAL_NAME>
trivanadate

> <INCHI_IDENTIFIER>
InChI=1S/6H2O.2O.3V/h6*1H2;;;;;/q;;;;;;;;3*+2/p-6

> <INCHI_KEY>
InChIKey=FUHNYNGYWNVWOA-UHFFFAOYSA-H

> <SMILES>
O[V](O)O[V](O)(O)O[V](O)O

> <JCHEM_ACCEPTOR_COUNT>
8

> <JCHEM_DONOR_COUNT>
6

> <JCHEM_ACIDIC_PKA>
15.85

> <JCHEM_BASIC_PKA>
-1.4

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_LOGP>
-2.7

> <JCHEM_POLARIZABILITY>
15.52

> <JCHEM_POLAR_SURFACE_AREA>
139.84

> <JCHEM_REFRACTIVITY>
18.09

> <JCHEM_ROTATABLE_BOND_COUNT>
4 __ 

$$$$
